Alnylam Pharmaceuticals - 22 Year Stock Price History | ALNY

Historical daily share price chart and data for Alnylam Pharmaceuticals since 2004 adjusted for splits and dividends. The latest closing stock price for Alnylam Pharmaceuticals as of January 20, 2026 is 355.53.

The all-time high Alnylam Pharmaceuticals stock closing price was 491.22 on October 20, 2025.
The Alnylam Pharmaceuticals 52-week high stock price is 495.55, which is 39.4% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 205.87, which is 42.1% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 354.56.

Alnylam Pharmaceuticals Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	383.8650	400.1700	422.5000	355.5300	355.5300	-10.59%
2025	347.8418	233.6200	491.2200	224.3200	397.6500	68.99%
2024	212.7635	194.9300	300.5500	143.3100	235.3100	22.94%
2023	192.3841	233.5900	235.5300	151.4100	191.4100	-19.46%
2022	174.8455	173.9100	241.3100	120.4200	237.6500	40.14%
2021	167.8841	128.1000	209.2900	126.8300	169.5800	30.48%
2020	131.5811	115.6200	165.4900	93.1200	129.9700	12.85%
2019	84.8380	72.7600	124.2300	65.8600	115.1700	57.96%
2018	101.1745	131.8500	148.5400	62.6700	72.9100	-42.61%
2017	80.4192	38.6400	139.9800	36.8800	127.0500	239.34%
2016	60.4803	93.0300	94.7700	31.4100	37.4400	-60.23%
2015	106.1700	97.7700	138.7300	75.0200	94.1400	-2.95%
2014	73.5115	63.8600	106.5900	48.8700	97.0000	50.86%
2013	40.1254	19.1700	66.9100	18.7300	64.3000	252.33%
2012	14.3445	8.6600	20.9900	8.6500	18.2500	123.93%
2011	8.7621	10.0100	11.3700	6.0000	8.1500	-17.34%
2010	14.9240	18.1400	18.7200	8.9600	9.8600	-44.04%
2009	20.1578	25.1500	25.9400	15.1400	17.6200	-28.75%
2008	27.1632	28.9200	35.9500	17.2900	24.7300	-14.96%
2007	23.7309	21.5700	36.5500	15.1600	29.0800	35.89%
2006	15.6631	12.9600	23.8100	11.6100	21.4000	60.66%
2005	9.2152	7.5800	14.1900	6.9000	13.3200	78.31%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$47.465B	$2.248B
Alnylam Pharmaceuticals Inc. is a development-stage biopharmaceutical company focused on the development of novel therapeutics based on RNA interference. The company's pipeline of experimental RNAi therapeutics is focused across three strategic therapeutic areas - genetic medicines, cardio-metabolic disease and hepatic infectious disease. The company's lead drug-Onpattro received regulatory approvals in the United States and Europe for the treatment of hereditary transthyretin-mediated amyloidosis in adults. The FDA approved Givlaari for acute hepatic porphyria. The FDA approved Oxlumo injection for subcutaneous use, for the treatment of primary hyperoxaluria type 1 to lower urinary oxalate levels in pediatric and adult patients. Moreover, the company is evaluating inclisiran for hypercholesterolemia in partnership with The Medicines Company acquired by Novartis. The FDA approved Leqvio to reduce low-density lipoprotein cholesterol with two doses a year..

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$292.780B	20.65
Amgen (AMGN)	United States	$177.919B	15.11
Gilead Sciences (GILD)	United States	$154.973B	15.25
Bristol Myers Squibb (BMY)	United States	$112.496B	8.42
Vertex Pharmaceuticals (VRTX)	United States	$111.981B	28.83
GSK (GSK)	United Kingdom	$98.292B	10.89
Regeneron Pharmaceuticals (REGN)	United States	$77.042B	19.99
CSL (CSLLY)	Australia	$57.238B	0.00
Argenex SE (ARGX)	Netherlands	$49.507B	61.16
Insmed (INSM)	United States	$34.427B	0.00
BioNTech SE (BNTX)	Germany	$24.545B	0.00
Biogen (BIIB)	United States	$24.121B	9.82
Revolution Medicines (RVMD)	United States	$23.253B	0.00
Royalty Pharma (RPRX)	United States	$22.830B	8.75
Genmab (GNMSF)	Denmark	$21.829B	16.01
Illumina (ILMN)	United States	$21.644B	32.49
Incyte (INCY)	United States	$20.851B	19.96
Genmab (GMAB)	Denmark	$20.717B	15.58
Exact Sciences (EXAS)	United States	$19.545B	539.10
Moderna (MRNA)	United States	$16.344B	0.00
Roivant Sciences (ROIV)	United Kingdom	$16.087B	0.00
Guardant Health (GH)	United States	$14.134B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$13.564B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	24.50
Ascendis Pharma (ASND)	Denmark	$12.757B	0.00
Exelixis (EXEL)	United States	$11.786B	18.87
Avidity Biosciences (RNA)	United States	$10.926B	0.00
Bio-Techne Corp (TECH)	United States	$10.700B	39.92
BioMarin Pharmaceutical (BMRN)	United States	$10.488B	19.02
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.294B	40.15
QIAGEN (QGEN)	Netherlands	$10.046B	19.07
Abivax SA (ABVX)	France	$9.186B	0.00
Repligen (RGEN)	United States	$9.120B	97.60
Axsome Therapeutics (AXSM)	United States	$8.937B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$8.675B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$8.381B	30.14
Halozyme Therapeutics (HALO)	United States	$8.374B	13.39
Krystal Biotech (KRYS)	United States	$8.265B	42.74
Praxis Precision Medicines (PRAX)	United States	$7.993B	0.00
Cytokinetics (CYTK)	United States	$7.651B	0.00
Nuvalent (NUVL)	United States	$7.580B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.782B	0.00
Vaxcyte (PCVX)	United States	$6.099B	0.00
PTC Therapeutics (PTCT)	United States	$5.819B	7.90
Belite Bio (BLTE)	United States	$5.819B	0.00
Cogent Biosciences (COGT)	United States	$5.544B	0.00
Apogee Therapeutics (APGE)	United States	$5.518B	0.00
ImmunityBio (IBRX)	United States	$5.437B	0.00
Structure Therapeutics (GPCR)	United States	$5.378B	0.00
Alkermes (ALKS)	Ireland	$5.223B	15.35
Protagonist Therapeutics (PTGX)	United States	$5.126B	132.24
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.100B	0.00
Kymera Therapeutics (KYMR)	United States	$5.003B	0.00
Celcuity (CELC)	United States	$4.949B	0.00
TG Therapeutics (TGTX)	United States	$4.853B	11.00
Anbio Biotechnology (NNNN)	Germany	$4.681B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$4.679B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.637B	4.70
Immunovant (IMVT)	United States	$4.605B	0.00
Scholar Rock Holding (SRRK)	United States	$4.587B	0.00
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.421B	358.25
CG Oncology (CGON)	United States	$4.415B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.397B	37.13
ADMA Biologics Inc (ADMA)	United States	$4.120B	29.34
Legend Biotech (LEGN)	United States	$4.089B	0.00
Arcellx (ACLX)	United States	$3.986B	0.00
Viking Therapeutics (VKTX)	United States	$3.834B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.798B	93.22
GRAIL (GRAL)	United States	$3.770B	0.00
Liquidia (LQDA)	United States	$3.300B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.297B	0.00
Viridian Therapeutics (VRDN)	United States	$3.174B	0.00
Beam Therapeutics (BEAM)	United States	$3.168B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.166B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.142B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.089B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.020B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$2.987B	87.58
Vera Therapeutics (VERA)	United States	$2.973B	0.00
Edgewise Therapeutics (EWTX)	United States	$2.900B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.800B	0.00
Erasca (ERAS)	United States	$2.729B	0.00
Disc Medicine (IRON)	United States	$2.678B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.675B	0.00
Denali Therapeutics (DNLI)	United States	$2.638B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.629B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.591B	0.00
Spyre Therapeutics (SYRE)	United States	$2.579B	0.00
Twist Bioscience (TWST)	United States	$2.537B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.525B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.523B	64.32
Travere Therapeutics (TVTX)	United States	$2.494B	0.00
Alumis (ALMS)	United States	$2.491B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.460B	6.68
Recursion Pharmaceuticals (RXRX)	United States	$2.428B	0.00
Arcus Biosciences (RCUS)	United States	$2.354B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.282B	0.00
Mesoblast (MESO)	Australia	$2.239B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.214B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.170B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.086B	11.39
Zai Lab (ZLAB)	China	$2.080B	0.00
Immunome (IMNM)	United States	$2.055B	0.00
Nuvation Bio (NUVB)	United States	$2.006B	0.00
Maze Therapeutics (MAZE)	United States	$1.962B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.906B	14.78
Vericel (VCEL)	United States	$1.891B	155.83
Dianthus Therapeutics (DNTH)	United States	$1.891B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.863B	0.00
Dynavax Technologies (DVAX)	United States	$1.835B	53.90
MBX Biosciences (MBX)	United States	$1.820B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.783B	0.00
Zymeworks (ZYME)	United States	$1.756B	0.00
Tango Therapeutics (TNGX)	United States	$1.752B	0.00
Sionna Therapeutics (SION)	United States	$1.745B	0.00
Celldex Therapeutics (CLDX)	United States	$1.704B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.685B	0.00
Upstream Bio (UPB)	United States	$1.675B	0.00
NeoGenomics (NEO)	United States	$1.655B	0.00
Stoke Therapeutics (STOK)	United States	$1.639B	42.84
MannKind (MNKD)	United States	$1.600B	52.10
Agios Pharmaceuticals (AGIO)	United States	$1.586B	0.00
Precigen (PGEN)	United States	$1.560B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.544B	74.09
Tyra Biosciences (TYRA)	United States	$1.536B	0.00
NovoCure (NVCR)	Jersey	$1.527B	0.00
Fortrea Holdings (FTRE)	United States	$1.525B	32.35
Certara (CERT)	United States	$1.515B	27.97
Alvotech (ALVO)	Luxembourg	$1.483B	21.39
Mind Medicine (MindMed) (DFTX)	United States	$1.483B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Nurix Therapeutics (NRIX)	United States	$1.477B	0.00
Intellia Therapeutics (NTLA)	United States	$1.448B	0.00
Kodiak Sciences (KOD)	United States	$1.440B	0.00
UniQure (QURE)	Netherlands	$1.423B	0.00
Biohaven (BHVN)	United States	$1.391B	0.00
Trevi Therapeutics (TRVI)	United States	$1.344B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.322B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.321B	0.00
Pharvaris (PHVS)	Netherlands	$1.312B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.309B	0.00
Novavax (NVAX)	United States	$1.302B	3.31
Pharming Group (PHAR)	Netherlands	$1.293B	0.00
Rapport Therapeutics (RAPP)	United States	$1.278B	0.00
AnaptysBio (ANAB)	United States	$1.265B	0.00
EyePoint (EYPT)	United States	$1.248B	0.00
Pharming Group (PHGUF)	Netherlands	$1.241B	185.00
AbCellera Biologics (ABCL)	Canada	$1.233B	0.00
Sana Biotechnology (SANA)	United States	$1.220B	0.00
Immatics (IMTX)	Germany	$1.195B	0.00
Palvella Therapeutics (PVLA)	United States	$1.180B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.180B	0.00
Castle Biosciences (CSTL)	United States	$1.168B	160.04
Septerna (SEPN)	United States	$1.167B	0.00
Zenas BioPharma (ZBIO)	United States	$1.082B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.077B	0.00
Inhibrx Biosciences (INBX)	United States	$1.051B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.043B	0.00
Nanobiotix S.A - (NBTX)	France	$1.016B	0.00
Compass Therapeutics (CMPX)	United States	$1.014B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$1.004B	0.00
Ventyx Biosciences (VTYX)	United States	$0.991B	0.00
Rapt Therapeutics (RAPT)	United States	$0.973B	0.00
Inventiva S.A (IVA)	France	$0.950B	0.00
Iovance Biotherapeutics (IOVA)	United States	$0.937B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Bicara Therapeutics (BCAX)	United States	$0.918B	0.00
CytomX Therapeutics (CTMX)	United States	$0.913B	13.48
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.913B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
GH Research (GHRS)	Ireland	$0.884B	0.00
Urogen Pharma (URGN)	United States	$0.880B	0.00
ArriVent BioPharma (AVBP)	United States	$0.861B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.856B	0.00
Vir Biotechnology (VIR)	United States	$0.843B	0.00
Geron (GERN)	United States	$0.836B	0.00
DBV Technologies S.A (DBVT)	France	$0.834B	0.00
Janux Therapeutics (JANX)	United States	$0.828B	0.00
Pacira BioSciences (PCRX)	United States	$0.824B	9.44
MiMedx (MDXG)	United States	$0.803B	14.26
YD Bio (YDES)		$0.798B	0.00
Arvinas (ARVN)	United States	$0.784B	0.00
Arbutus Biopharma (ABUS)	United States	$0.781B	0.00
MapLight Therapeutics (MPLT)	United States	$0.771B	0.00
Gyre Therapeutics (GYRE)	United States	$0.740B	96.00
Kura Oncology (KURA)	United States	$0.736B	0.00
Annexon (ANNX)	United States	$0.726B	0.00
Jade Biosciences (JBIO)	United States	$0.725B	0.00
BioAge Labs (BIOA)	United States	$0.723B	0.00
Prime Medicine (PRME)	United States	$0.718B	0.00
Astria Therapeutics (ATXS)	United States	$0.712B	0.00
Cytek Biosciences (CTKB)	United States	$0.690B	0.00
REGENXBIO (RGNX)	United States	$0.689B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.633B	0.00
EnGene Holdings (ENGN)	Canada	$0.624B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$0.601B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.597B	0.00
Gossamer Bio (GOSS)	United States	$0.583B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.579B	0.00
Emergent Biosolutions (EBS)	United States	$0.577B	5.55
Keros Therapeutics (KROS)	United States	$0.575B	12.25
LENZ Therapeutics (LENZ)	United States	$0.572B	0.00
Invivyd (IVVD)	United States	$0.571B	0.00
SELLAS Life Sciences (SLS)	United States	$0.567B	0.00
Replimune (REPL)	United States	$0.552B	0.00
Myriad Genetics (MYGN)	United States	$0.552B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.549B	0.00
CorMedix Inc (CRMD)	United States	$0.534B	4.95
Alto Neuroscience (ANRO)	United States	$0.533B	0.00
Evommune (EVMN)	United States	$0.530B	0.00
Design Therapeutics (DSGN)	United States	$0.529B	0.00
Ocugen (OCGN)	United States	$0.528B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.505B	0.00
Prothena (PRTA)	Ireland	$0.503B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.498B	0.00
Niagen Bioscience (NAGE)	United States	$0.494B	38.69
Northwest Biotherapeutics (NWBO)	United States	$0.474B	0.00
Kamada (KMDA)	Israel	$0.470B	22.69
Monopar Therapeutics (MNPR)	United States	$0.468B	0.00
PureTech Health (PRTC)	United States	$0.464B	0.00
Absci (ABSI)	United States	$0.454B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.452B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.448B	0.00
Anavex Life Sciences (AVXL)	United States	$0.448B	0.00
Verastem (VSTM)	United States	$0.446B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.441B	0.00
Prima BioMed (IMMP)	Australia	$0.433B	0.00
NovaBridge Biosciences (NBP)	United States	$0.430B	0.00
Solid Biosciences (SLDB)	United States	$0.426B	0.00
Entrada Therapeutics (TRDA)	United States	$0.420B	0.00
Forte Biosciences (FBRX)	United States	$0.418B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.406B	0.00
Benitec Biopharma (BNTC)	United States	$0.396B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.394B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.394B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.367B	0.00
Allogene Therapeutics (ALLO)	United States	$0.366B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.366B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.364B	0.00
BGM Group (BGM)	China	$0.362B	0.00
PepGen (PEPG)	United States	$0.357B	0.00
AC Immune (ACIU)	Switzerland	$0.352B	0.00
Tectonic Therapeutic (TECX)	United States	$0.352B	0.00
Candel Therapeutics (CADL)	United States	$0.351B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.345B	0.00
Contineum Therapeutics (CTNM)	United States	$0.343B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.340B	0.00
Neumora Therapeutics (NMRA)	United States	$0.338B	0.00
Aardvark Therapeutics (AARD)	United States	$0.335B	0.00
XOMA Royalty (XOMA)	United States	$0.327B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.324B	0.00
Puma Biotechnology (PBYI)	United States	$0.321B	8.61
Aura Biosciences (AURA)	United States	$0.319B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.315B	0.00
Zura Bio (ZURA)	United States	$0.313B	0.00
Lifecore Biomedical (LFCR)	United States	$0.308B	0.00
Amarin (AMRN)	Ireland	$0.307B	0.00
GENFIT S.A (GNFTY)	France	$0.299B	0.00
Immuneering (IMRX)	United States	$0.296B	0.00
Shattuck Labs (STTK)	United States	$0.294B	0.00
Climb Bio (CLYM)	United States	$0.288B	0.00
Abeona Therapeutics (ABEO)	United States	$0.285B	4.65
Neurogene (NGNE)	United States	$0.272B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.266B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.264B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.263B	0.00
Adherex Technologies (FENC)	United States	$0.259B	0.00
Jyong Biotech (MENS)	Taiwan	$0.253B	0.00
Rezolute (RZLT)	United States	$0.253B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.253B	0.00
Immix Biopharma (IMMX)	United States	$0.249B	0.00
Palisade Bio (PALI)	United States	$0.247B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.238B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Nuvectis Pharma (NVCT)	United States	$0.217B	0.00
C4 Therapeutics (CCCC)	United States	$0.216B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.214B	0.00
Cabaletta Bio (CABA)	United States	$0.212B	0.00
Compugen (CGEN)	Israel	$0.211B	0.00
Voyager Therapeutics (VYGR)	United States	$0.209B	0.00
Humacyte (HUMA)	United States	$0.208B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.207B	0.00
Alector (ALEC)	United States	$0.201B	0.00
Sagimet Biosciences (SGMT)	United States	$0.200B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.200B	0.00
Editas Medicine (EDIT)	United States	$0.198B	0.00
Quince Therapeutics (QNCX)	United States	$0.198B	0.00
Cardiff Oncology (CRDF)	United States	$0.194B	0.00
Coherus Oncology (CHRS)	United States	$0.193B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.193B	0.00
SAB Biotherapeutics (SABS)	United States	$0.189B	0.00
Crescent Biopharma (CBIO)	United States	$0.188B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.182B	0.00
Alpha Teknova (TKNO)	United States	$0.178B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.175B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.174B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.170B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.169B	0.00
Alps Group (ALPS)	United States	$0.165B	3.00
Vor Biopharma (VOR)		$0.164B	0.00
Innate Pharma S.A (IPHA)	France	$0.163B	0.00
Codexis (CDXS)	United States	$0.151B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.146B	7.11
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Nkarta (NKTX)	United States	$0.145B	0.00
Opus Genetics (IRD)	United States	$0.145B	0.00
Seres Therapeutics (MCRB)	United States	$0.144B	0.00
Elicio Therapeutics (ELTX)	United States	$0.144B	0.00
VTv Therapeutics (VTVT)	United States	$0.140B	0.00
Fate Therapeutics (FATE)	United States	$0.137B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.137B	0.00
Caribou Biosciences (CRBU)	United States	$0.136B	0.00
Spero Therapeutics (SPRO)	United States	$0.136B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.135B	0.00
MaxCyte (MXCT)	United States	$0.134B	0.00
Turn Therapeutics (TTRX)	United States	$0.134B	0.00
Anika Therapeutics (ANIK)	United States	$0.134B	0.00
Actuate Therapeutics (ACTU)	United States	$0.132B	0.00
Cognition Therapeutics (CGTX)	United States	$0.129B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.127B	0.00
Alpha Cognition (ACOG)	Canada	$0.124B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.121B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.121B	0.00
Sutro Biopharma (STRO)	United States	$0.118B	0.00
Fortress Biotech (FBIO)	United States	$0.115B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.114B	0.00
Agenus (AGEN)	United States	$0.114B	0.00
Ovid Therapeutics (OVID)	United States	$0.112B	0.00
Repare Therapeutics (RPTX)	Canada	$0.111B	0.00
Tharimmune (THAR)	United States	$0.109B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.108B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.107B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.106B	0.00
Seer (SEER)	United States	$0.105B	0.00
Genelux (GNLX)	United States	$0.104B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.102B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.101B	0.00
Tenax Therapeutics (TENX)	United States	$0.100B	0.00
Biomea Fusion (BMEA)	United States	$0.100B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Scilex Holding (SCLX)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Adagene (ADAG)	China	$0.092B	0.00
Coya Therapeutics (COYA)	United States	$0.090B	0.00
Citius Oncology (CTOR)	United States	$0.089B	0.00
EXoZymes (EXOZ)	United States	$0.088B	0.00
OKYO Pharma (OKYO)		$0.083B	0.00
BioHarvest Sciences (BHST)	Canada	$0.080B	0.00
Adicet Bio (ACET)	United States	$0.079B	0.00
Pliant Therapeutics (PLRX)	United States	$0.079B	0.00
Spruce Biosciences (SPRB)	United States	$0.079B	0.00
MediciNova (MNOV)	United States	$0.079B	0.00
XBiotech (XBIT)	United States	$0.078B	0.00
Annovis Bio (ANVS)	United States	$0.077B	0.00
Immunic (IMUX)	United States	$0.074B	0.00
Entera Bio (ENTX)	Israel	$0.074B	0.00
CalciMedica (CALC)	United States	$0.074B	0.00
ImageneBio (IMA)	United States	$0.073B	0.00
BioStem Technologies (BSEM)		$0.071B	4.94
Equillium (EQ)	United States	$0.070B	0.00
ATyr Pharma (ATYR)	United States	$0.069B	0.00
BeyondSpring (BYSI)	United States	$0.069B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.068B	0.00
CervoMed (CRVO)	United States	$0.067B	0.00
InflaRx (IFRX)	Germany	$0.067B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.067B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.066B	0.00
TScan Therapeutics (TCRX)	United States	$0.064B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.063B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.061B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.061B	0.00
Grace Therapeutics (GRCE)	United States	$0.056B	0.00
MiNK Therapeutics (INKT)	United States	$0.056B	0.00
Clene (CLNN)	United States	$0.055B	0.00
Precision BioSciences (DTIL)	United States	$0.054B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.052B	0.00
IBio (IBIO)	United States	$0.049B	0.00
ABVC BioPharma (ABVC)	United States	$0.049B	0.00
Aligos Therapeutics (ALGS)	United States	$0.049B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
PDS Biotechnology (PDSB)	United States	$0.047B	0.00
INmune Bio (INMB)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
NextCure (NXTC)	United States	$0.045B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.045B	0.00
Q32 Bio (QTTB)	United States	$0.044B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.043B	0.00
Jasper Therapeutics (JSPR)	United States	$0.043B	0.00
Cingulate (CING)	United States	$0.042B	0.00
TELA Bio (TELA)	United States	$0.041B	0.00
Passage Bio (PASG)	United States	$0.041B	0.00
OnKure Therapeutics (OKUR)	United States	$0.041B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.040B	0.00
Galecto (GLTO)	Denmark	$0.040B	0.00
Exicure (XCUR)	United States	$0.040B	0.00
TuHURA Biosciences (HURA)	United States	$0.039B	0.00
Lantern Pharma (LTRN)	United States	$0.038B	0.00
Femasys (FEMY)	United States	$0.038B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.038B	0.00
Estrella Immunopharma (ESLA)	United States	$0.038B	0.00
RenovoRx (RNXT)	United States	$0.037B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.037B	0.00
IO Biotech (IOBT)	Denmark	$0.036B	0.00
Oncobiologics (OTLK)	United States	$0.035B	0.00
Elutia (ELUT)	United States	$0.035B	0.00
Medicus Pharma (MDCX)	United States	$0.035B	0.00
Xilio Therapeutics (XLO)	United States	$0.034B	0.00
AN2 Therapeutics (ANTX)	United States	$0.033B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.033B	2.08
Pluri (PLUR)	Israel	$0.032B	0.00
Skye Bioscience (SKYE)	United States	$0.032B	0.00
Rein Therapeutics (RNTX)	United States	$0.032B	0.00
Dyadic (DYAI)	United States	$0.031B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.030B	0.00
Boundless Bio (BOLD)	United States	$0.028B	0.00
Rallybio (RLYB)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Aytu BioPharma (AYTU)	United States	$0.027B	0.00
Senti Biosciences (SNTI)	United States	$0.027B	0.00
Quantum Biopharma (QNTM)	Canada	$0.027B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.027B	0.00
Hyperion DeFi (HYPD)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.026B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.025B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.025B	0.00
Intensity Therapeutics (INTS)	United States	$0.025B	0.00
Athira Pharma (LONA)	United States	$0.024B	0.00
Cue Biopharma (CUE)	United States	$0.024B	0.00
Apollomics (APLM)	United States	$0.023B	0.00
FibroBiologics (FBLG)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.021B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.019B	0.00
Lisata Therapeutics (LSTA)	United States	$0.019B	0.00
BioAtla (BCAB)	United States	$0.019B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.019B	0.00
Allarity Therapeutics (ALLR)	United States	$0.019B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.018B	0.00
Promis Neurosciences (PMN)	Canada	$0.018B	0.00
Polyrizon (PLRZ)	Israel	$0.016B	0.00
Hoth Therapeutics (HOTH)	United States	$0.016B	0.00
Black Titan (BTTC)	United States	$0.015B	0.00
Applied Therapeutics (APLT)	United States	$0.015B	0.00
Cocrystal Pharma (COCP)	United States	$0.015B	0.00
Bionano Genomics (BNGO)	United States	$0.015B	0.00
BioCardia (BCDA)	United States	$0.015B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
Beyond Air (XAIR)	United States	$0.014B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.013B	0.00
Synlogic (SYBX)	United States	$0.013B	0.00
Curis (CRIS)	United States	$0.013B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.012B	0.00
Edesa Biotech (EDSA)	Canada	$0.012B	0.00
Novogen (KZIA)	Australia	$0.012B	0.00
Longeveron (LGVN)	United States	$0.012B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
IN8bio (INAB)	United States	$0.011B	0.00
NewcelX (NCEL)	Switzerland	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.011B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.010B	0.00
Biorestorative Therapies (BRTX)	United States	$0.010B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.010B	0.00
Gelteq (GELS)	Australia	$0.010B	0.00
Biofrontera (BFRI)	United States	$0.010B	0.00
Abpro Holdings (ABP)	United States	$0.010B	0.00
GENPREX (GNPX)	United States	$0.009B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.009B	0.00
IMMURON (IMRN)	Australia	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.008B	0.00
Mustang Bio (MBIO)	United States	$0.008B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
MetaVia (MTVA)	United States	$0.007B	0.00
KALA BIO (KALA)	United States	$0.007B	0.00
Advanced Biomed (ADVB)	United States	$0.006B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.006B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.006B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.006B	0.00
Aprea Therapeutics (APRE)	United States	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.006B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.006B	0.00
Revelation Biosciences (REVB)	United States	$0.006B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
Avalon GloboCare (ALBT)	United States	$0.005B	0.00
HCW Biologics (HCWB)	United States	$0.005B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.004B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Ensysce Biosciences (ENSC)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Onconetix (ONCO)	United States	$0.003B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Enveric Biosciences (ENVB)	United States	$0.002B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Psyence Biomedical (PBM)	Canada	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00